Ready-to-Use Biomarker Panels: Oncology Collection
From tumor initiation to therapeutic response, oncology research increasingly depends on biomarker data that must be robust, translatable, and clinically meaningful. Clinicians and translational teams now require the simultaneous assessment of an expanding number of biomarkers to better capture tumor heterogeneity, mechanisms of resistance, and patient response to therapy.
To expedite your research and minimize development costs, we have translated our years of oncology biomarker expertise into 24 ready-to-use panels. These panels are designed to address key oncology questions that are critical for understanding disease biology and therapeutic response, including for example:
- Tumor characterization
- Immune contexture
- Pathway activation
- Target engagement
- Patient Stratification
Download the brochure to view a full list of panels and biomarkers in our Oncology Collection.
Ready-to-Use Biomarker Panels: Immunology & Inflammation Collection
From disease onset to therapeutic response, Immunology and Inflammation research increasingly relies on biomarker data that must be robust, translatable, and biologically meaningful. Clinicians and translational teams now require the simultaneous assessment of growing numbers of biomarkers to better capture disease complexity, patient heterogeneity, and treatment response.
To expedite your research and minimize development costs, we have translated our years of immunology and inflammatory biomarker expertise into 23 ready-to-use panels. These panels are designed to address key disease-relevant questions about disease onset, progression, and response to therapy, including for example:
- Immune cell activation and differentiation
- Cytokine and chemokine signaling
- Tissue inflammation
- Pathway dysregulation
- Patient stratification
Download the brochure to view a full list of panels and biomarkers in our Immunology & Inflammation Collection.
Aliri Overview brochure
The increased focus on precision medicine, oncology and other therapies has changed how companies are planning for drug discovery and clinical development. There are many challenges to navigate, including:
- Robust regulatory environment
- Developing a thorough program but also advancing with speed
- Having access to a breadth of technical expertise to assist
- And much more…
This is why choosing a partner like Aliri is critical to the success of your program. We provide a range of bioanalysis, spatial bioanalytical, and spatial biology services to support the lifecycle of your drug. Our labs have proven operational excellence across a range of traditional and innovative technologies, and the experience to support the unique needs of your development program.
Utilize our team of seasoned scientists and technical experts to help advance your molecule from discovery through clinical:
- Access quality data for filing your IND, NDA, or CTA with speed
- Anticipate technical issues or potential roadblocks that may cause delays
- Showcase drug efficacy in the pertinent spatial context up to the cellular level to improve drug candidate evaluation and selection
- Maximize the value of your drug discovery and development investments
Check out our company overview to learn more about our services and how we can work together to provide you with accurate data FAST.